Article
Osimertinib-associated Membranoproliferative Glomerulonephritis: a Case Report
2023-12-06
Abstract excerpt
Osimertinib is a third-generation epidermal growth factor receptor-directed tyrosine kinase inhibitor (EGFR-TKIs) that selectively binds to T790M mutation and used in EGFR-positive non-small cell lung cancer (NSCLC), which has shown to improve progression-free survival. While there have been reports of first- and second-generation EGFR-TKIs causing acute tubulointerstitial nephritis, there have been limited case r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8d55db9d-2837-5d56-a285-08f38a382f32
- DOI
- 10.21203/rs.3.rs-3667078/v1
